Trial intelligence / Profile preview

Bilastine effects on nasal volume after allergen-induced rhinitis

2011-004830-32Phase 4Active

Sponsor
Faes Farma
Start
Nov 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of bilastine in allergic rhinitis (AR), sponsored by Faes Farma. Started Nov 2011; status: active.

02

Drugs

bilastine
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on 2011-004830-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-004830-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call